David S. Salomon focuses on Epidermal growth factor, Molecular biology, Cancer research, Endocrinology and Internal medicine. He works on Epidermal growth factor which deals in particular with Cripto. His research integrates issues of Cell culture, Autocrine signalling, Cell, Cell growth and TGF alpha in his study of Molecular biology.
His Cancer research research is multidisciplinary, incorporating elements of ErbB Receptors, Epidermal growth factor receptor, Receptor, Gefitinib and ErbB. His study in Endocrinology is interdisciplinary in nature, drawing from both Morphogenesis, Growth factor and In vivo. The study incorporates disciplines such as Chemotaxis, Transforming growth factor, Type IV collagen and Cytokine in addition to Growth factor.
Cancer research, Cripto, Epidermal growth factor, Internal medicine and Cell biology are his primary areas of study. The concepts of his Cancer research study are interwoven with issues in Cancer, Breast cancer, Epidermal growth factor receptor, Immunology and Pathology. David S. Salomon has included themes like Carcinogenesis, Epithelial–mesenchymal transition, Protein kinase B and NODAL in his Cripto study.
David S. Salomon has researched Epidermal growth factor in several fields, including Transforming growth factor, Growth factor and Molecular biology. His Internal medicine study integrates concerns from other disciplines, such as Epithelium, Endocrinology and Oncology. His Cell biology research integrates issues from Embryonic stem cell and Cellular differentiation.
David S. Salomon mostly deals with Cancer research, Cell biology, Cripto, Cancer stem cell and Stem cell. His studies deal with areas such as Cancer, Breast cancer, In vivo and Pathology as well as Cancer research. His Cell biology research incorporates elements of Embryonic stem cell, Endocrinology, Cellular differentiation and Cell growth.
David S. Salomon focuses mostly in the field of Endocrinology, narrowing it down to topics relating to Epidermal growth factor and, in certain cases, Lewis lung carcinoma and Progesterone receptor. Cripto is a subfield of Internal medicine that David S. Salomon investigates. His Signal transduction study incorporates themes from Receptor, Molecular biology, Phosphorylation and Brachyury.
David S. Salomon mainly investigates Cell biology, Stem cell, Cancer stem cell, Cripto and Cancer research. In his work, Induced pluripotent stem cell, Cell growth and Embryonic stem cell is strongly intertwined with Cellular differentiation, which is a subfield of Cell biology. His Stem cell research includes themes of Protein kinase B, Wnt signaling pathway and Homeobox protein NANOG.
The Cripto study combines topics in areas such as Epithelial–mesenchymal transition, Breast cancer, Triple-negative breast cancer, Regulation of gene expression and Adenocarcinoma. As part of one scientific family, he deals mainly with the area of Cancer research, narrowing it down to issues related to the Immunology, and often Endocytosis, Mammary gland morphogenesis, Receptor tyrosine kinase and Caveolae. As a part of the same scientific family, David S. Salomon mostly works in the field of Cell signaling, focusing on Tumor microenvironment and, on occasion, Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidermal growth factor-related peptides and their receptors in human malignancies
David S. Salomon;Ralf Brandt;Fortunato Ciardiello;Nicola Normanno.
Critical Reviews in Oncology Hematology (1995)
Epidermal growth factor receptor (EGFR) signaling in cancer
Nicola Normanno;Antonella De Luca;Caterina Bianco;Luigi Strizzi.
Gene (2006)
A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.
Fusao Hirata;Elliott Schiffmann;Krishnamoorthy Venkatasubramanian;David Salomon.
Proceedings of the National Academy of Sciences of the United States of America (1980)
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
N Normanno;C Bianco;A De Luca;M R Maiello.
Endocrine-related Cancer (2003)
Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance
Susan E. Bates;Nancy E. Davidson;Eva M. Valverius;Carl E. Freter.
Molecular Endocrinology (1988)
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
N. Normanno;M. Campiglio;A. De Luca;G. Somenzi.
Annals of Oncology (2002)
The ErbB receptors and their ligands in cancer: an overview.
N. Normanno;C. Bianco;L. Strizzi;M. Mancino.
Current Drug Targets (2005)
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells.
P. Garcia-Morales;M. Saceda;N. Kenney;N. Kim.
Journal of Biological Chemistry (1994)
Differential expression of epidermal growth factor-related proteins in human colorectal tumors.
F Ciardiello;N Kim;T Saeki;R Dono.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Presence of Transforming Growth Factors in Human Breast Cancer Cells
David S. Salomon;James A. Zwiebel;Mozeena Bano;Ilona Losonczy.
Cancer Research (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Campania "Luigi Vanvitelli"
Okayama University
National Institutes of Health
University of Kent
National Institutes of Health
Northwestern University
National Institutes of Health
University of Verona
National Institute of Environmental Health Sciences
Columbia University
University College London
Vrije Universiteit Amsterdam
Brown University
Texas A&M University
University of Tokyo
Michigan State University
University of Science and Technology of China
University of Minnesota
Swiss Tropical and Public Health Institute
Chinese Academy of Sciences
New Mexico Institute of Mining and Technology
Université Paris Cité
Florida International University
University of Jyväskylä
Yamaguchi University
Cardiff University